• Oruka Therapeutics Chief Medical Officer Joana Goncalves reported option and warrant exercises totaling 7,000 shares on May 15, 2026, at exercise prices of $6.84 and $7.8.
• Goncalves also sold 7,000 shares on May 15, 2026, at prices of about $61.56, $62.42, and $63.52.
• Holdings in common stock ended day at 33,377 shares.
• Derivative holdings following transactions totaled 207,563 employee stock options and 178,992 employee warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000039), on May 15, 2026, and is solely responsible for the information contained therein.